- Home
- CVKD vs IMCC Comparison
CVKD vs IMCC Comparison
Compare CVKD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- IMCC
- Stock Information
- Founded
- CVKD 2022
- IMCC 1980
- Country
- CVKD United States
- IMCC Israel
- Employees
- CVKD N/A
- IMCC N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- CVKD Health Care
- IMCC Health Care
- Exchange
- CVKD Nasdaq
- IMCC Nasdaq
- Market Cap
- CVKD 29.5M
- IMCC 5.3M
- IPO Year
- CVKD 2023
- IMCC N/A
- Fundamental
- Price
- CVKD $12.80
- IMCC $2.91
- Analyst Decision
- CVKD Strong Buy
- IMCC
- Analyst Count
- CVKD 1
- IMCC 0
- Target Price
- CVKD $32.00
- IMCC N/A
- AVG Volume (30 Days)
- CVKD 32.3K
- IMCC 147.9K
- Earning Date
- CVKD 08-06-2025
- IMCC 08-13-2025
- Dividend Yield
- CVKD N/A
- IMCC N/A
- EPS Growth
- CVKD N/A
- IMCC N/A
- EPS
- CVKD N/A
- IMCC N/A
- Revenue
- CVKD N/A
- IMCC $37,894,737.00
- Revenue This Year
- CVKD N/A
- IMCC $47.12
- Revenue Next Year
- CVKD N/A
- IMCC $12.83
- P/E Ratio
- CVKD N/A
- IMCC N/A
- Revenue Growth
- CVKD N/A
- IMCC 12.68
- 52 Week Low
- CVKD $5.70
- IMCC $1.29
- 52 Week High
- CVKD $22.90
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- CVKD 49.60
- IMCC 55.33
- Support Level
- CVKD $11.00
- IMCC $2.37
- Resistance Level
- CVKD $13.71
- IMCC $2.95
- Average True Range (ATR)
- CVKD 1.14
- IMCC 0.42
- MACD
- CVKD 0.10
- IMCC -0.03
- Stochastic Oscillator
- CVKD 63.54
- IMCC 56.93
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.